AAM
WST icon

Azzad Asset Management’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.31M Buy
10,579
+274
+3% +$59.9K 0.25% 158
2025
Q1
$2.31M Buy
+10,305
New +$2.31M 0.27% 146
2024
Q4
Sell
-10,159
Closed -$3.05M 309
2024
Q3
$3.05M Buy
10,159
+1,289
+15% +$387K 0.34% 100
2024
Q2
$2.92M Sell
8,870
-4,450
-33% -$1.47M 0.34% 97
2024
Q1
$5.27M Buy
13,320
+993
+8% +$393K 0.61% 35
2023
Q4
$4.34M Sell
12,327
-252
-2% -$88.7K 0.55% 39
2023
Q3
$4.72M Sell
12,579
-80
-0.6% -$30K 0.67% 26
2023
Q2
$4.84M Sell
12,659
-145
-1% -$55.5K 0.65% 27
2023
Q1
$4.44M Sell
12,804
-32
-0.2% -$11.1K 0.63% 33
2022
Q4
$3.02M Buy
12,836
+4,796
+60% +$1.13M 0.48% 59
2022
Q3
$1.98M Buy
8,040
+113
+1% +$27.8K 0.2% 169
2022
Q2
$2.4M Sell
7,927
-40
-0.5% -$12.1K 0.24% 141
2022
Q1
$3.27M Buy
7,967
+469
+6% +$193K 0.47% 58
2021
Q4
$3.52M Buy
7,498
+259
+4% +$121K 0.47% 57
2021
Q3
$3.07M Sell
7,239
-60
-0.8% -$25.5K 0.45% 61
2021
Q2
$2.62M Sell
7,299
-601
-8% -$216K 0.39% 80
2021
Q1
$2.23M Buy
+7,900
New +$2.23M 0.37% 99
2016
Q4
Sell
-4,630
Closed -$345K 241
2016
Q3
$345K Sell
4,630
-2,834
-38% -$211K 0.14% 211
2016
Q2
$566K Sell
7,464
-825
-10% -$62.6K 0.24% 153
2016
Q1
$575K Buy
8,289
+190
+2% +$13.2K 0.25% 154
2015
Q4
$488K Buy
8,099
+88
+1% +$5.3K 0.23% 158
2015
Q3
$434K Buy
8,011
+267
+3% +$14.4K 0.23% 159
2015
Q2
$450K Sell
7,744
-35
-0.4% -$2.03K 0.23% 172
2015
Q1
$468K Buy
7,779
+792
+11% +$47.7K 0.23% 173
2014
Q4
$372K Buy
6,987
+328
+5% +$17.5K 0.2% 204
2014
Q3
$298K Sell
6,659
-341
-5% -$15.3K 0.17% 236
2014
Q2
$295K Buy
7,000
+141
+2% +$5.95K 0.18% 223
2014
Q1
$302K Buy
6,859
+409
+6% +$18K 0.2% 214
2013
Q4
$316K Buy
6,450
+244
+4% +$12K 0.23% 180
2013
Q3
$255K Hold
6,206
0.21% 191
2013
Q2
$255K Buy
+6,206
New +$255K 0.22% 189